At-Home Sexually Transmitted Infection (STI) Testing Market Report 2026

At-Home Sexually Transmitted Infection (STI) Testing Market Overview

• At-Home Sexually Transmitted Infection (STI) Testing market size has reached to $1.93 billion in 2025 • Expected to grow to $3.55 billion in 2030 at a compound annual growth rate (CAGR) of 13% • Growth Driver: Growing Awareness Of Sexual Health Driving The At-Market Growth Due To Rising STI Burden And Demand For Private, Accessible Testing • Market Trend: Advancement In Rapid At-Home PCR Technology Enhances Speed, Accuracy, And Consumer Access To STI Diagnostics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under At-Home Sexually Transmitted Infection (STI) Testing Market?

At-home sexually transmitted infection (STI) testing refers to diagnostic kits that enable individuals to collect their own samples in a private setting, which are then either sent to accredited laboratories or analyzed using rapid test methods at home. The key objective is to enhance accessibility, confidentiality, and convenience in STI screening, supporting early diagnosis and prompt treatment while minimizing stigma and obstacles linked to traditional clinic-based testing. The main types of at-home sexually transmitted infection (STI) testing include rapid lateral flow immunoassays, molecular or nucleic acid amplification technology (NAAT)-based kits, multiplex panel testing, and other types. Rapid lateral flow immunoassays refer to simple, quick testing methods that detect the presence of specific STI markers in a sample for preliminary diagnosis at home. These solutions are based on infections such as human immunodeficiency virus (HIV), Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), syphilis, trichomoniasis, human papillomavirus (HPV), hepatitis B and C, and other infections and they utilize sample types including blood samples, urine samples, and swab samples. The various distributions involved are online pharmacies and D2C platforms, retail pharmacies, public health distribution programs, and other distributions, and they are used by several end users such as individual consumers, healthcare providers, and public health programs.

What Is The At-Home Sexually Transmitted Infection (STI) Testing Market Growth Forecast?

The at-home sexually transmitted infection (STI) testing market size is expected to see rapid growth in the next few years.It will grow to $3.55 billion by 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to growing adoption of AI-enabled digital sexual health platforms, rising demand for multiplex and rapid at-home STI diagnostic kits, increasing integration of connected and app-based testing ecosystems, expanding availability of D2C healthcare distribution channels, growing focus on preventive sexual wellness and routine screening practices.Major trends in the forecast period include increasing adoption of discreet self-collection STI screening kits for private home-based testing, growing demand for rapid turnaround sexually transmitted infection diagnostic solutions, rising preference for mail-in laboratory sexual health testing services among young adults, increasing availability of multi infection at-home sexual wellness testing panels, growing expansion of online pharmacy and direct-to-consumer sexual health testing distribution channels.

Global At-Home Sexually Transmitted Infection (STI) Testing Market Segmentation

1) By Type: Rapid Lateral Flow Immunoassays, Molecular Or Nucleic Acid Amplification Technology (NAAT)-Based Kits, Multiplex Panel Testing, Other Types 2) By Infection: Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG), Syphilis, Trichomoniasis, Human Papillomavirus (HPV), Hepatitis B And C, Other Infections 3) By Sample: Blood Samples, Urine Samples, Swab Samples 4) By Distribution: Online Pharmacies And D2C Platforms, Retail Pharmacies, Public Health Distribution Programs, Other Distributions 5) By End User: Individual Consumers, Healthcare Providers, Public Health Programs Subsegments: 1) By Rapid Lateral Flow Immunoassays: Of Human Immunodeficiency Virus Antibody Detection, Of Syphilis Antibody Detection, Of Chlamydia Antigen Detection, Of Gonorrhea Antigen Detection, Of Hepatitis B Surface Antigen Detection 2) By Molecular Or Nucleic Acid Amplification Technology (NAAT) Based Kits: Of Human Immunodeficiency Virus Nucleic Acid Detection, Of Chlamydia Trachomatis Nucleic Acid Detection, Of Neisseria Gonorrhoeae Nucleic Acid Detection, Of Trichomonas Vaginalis Nucleic Acid Detection, Of Mycoplasma Genitalium Nucleic Acid Detection 3) By Multiplex Panel Testing: Of Combined Human Immunodeficiency Virus And Syphilis Detection, Of Combined Chlamydia And Gonorrhea Detection, Of Comprehensive Bacterial Sexually Transmitted Infection Panel, Of Comprehensive Viral Sexually Transmitted Infection Panel, Of Multi Pathogen Sexual Health Screening Panel 4) By Other Types: Self-Collection Sample Kits, Mail-In Laboratory Testing Kits, Digital Or Connected At-Home Testing Kits, Microfluidic Lab-On-Chip Testing Kits

What Is The Driver Of The At-Home Sexually Transmitted Infection (STI) Testing Market?

The growing awareness of sexual health is expected to propel the growth of the at-home sexually transmitted infection (STI) testing industry going forward.Sexual health awareness refers to individuals' knowledge of STIs, their transmission routes, prevention methods, and the importance of regular testing for early detection and treatment.The increasing focus on sexual health awareness is largely driven by public health campaigns and the destigmatization of STI testing, which encourages more individuals to proactively seek information and testing options.The rising awareness of sexual health boosts demand for at-home STI testing as it motivates individuals to seek confidential, convenient, and accessible testing solutions outside of traditional clinical settings.For instance, in December 2025, according to the UK Health Security Agency, a UK-based government agency, infectious syphilis diagnoses rose by 1.7%, increasing from 9,375 cases in 2023 to 9,535 cases in 2024.Therefore, growing awareness of sexual health is driving the growth of the at-home sexually transmitted infection (STI) testing industry.

Key Players In The Global At-Home Sexually Transmitted Infection (STI) Testing Market

Major companies operating in the at-home sexually transmitted infection (sti) testing market are Becton Dickinson and Company (BD), Laboratory Corporation of America Holdings, Randox Laboratories Ltd, LetsGetChecked, Everly Health Inc, myLAB Box LLC, Preventx Ltd, MySTDTestKits, RapidTest. co. uk Ltd, Got Lucky Labs Inc, Biopanda Reagents Ltd, Rapid Labs Ltd, Walk-In Lab LLC, Any Lab Test Now Inc, 4U Health Ltd, Quest Diagnostics Incorporated, ACON Biotech (Hangzhou) Co. Ltd, UroSure Inc, Yoxly Ltd, Genedia Co. Ltd

Global At-Home Sexually Transmitted Infection (STI) Testing Market Trends and Insights

Major companies operating in the at-home STI testing market are focusing on developing advanced diagnostic technologies, such as instrument-free polymerase chain reaction platforms, to enhance detection accuracy, reduce turnaround time, and expand access to laboratory-grade results from home. Instrument-free polymerase chain reaction platforms refer to self-contained molecular diagnostic devices that enable users to collect samples at home and obtain highly accurate pathogen detection results without requiring traditional laboratory equipment, while integrating digital systems for secure result delivery and telehealth support. For instance, in November 2025, Visby Medical, a US-based medical diagnostics company, launched its FDA-authorized at-home PCR test for sexually transmitted infections, which detects chlamydia, gonorrhea, and trichomoniasis, delivers results in approximately 30 minutes, operates as an instrument-free single-use device, and integrates with digital platforms to provide secure result reporting and virtual care follow-up. It is designed to support direct-to-consumer access, enhance molecular accuracy, improve testing convenience, and enable seamless telehealth-enabled treatment guidance.

What Are Latest Mergers And Acquisitions In The At-Home Sexually Transmitted Infection (STI) Testing Market?

In September 2025, Tia Health, a US-based modern women’s healthcare platform, partnered with Molecular Testing Labs to launch the first-ever FDA-cleared home-collected 4-plex STI test. Through this partnership, the companies aim to improve access to at-home sexually transmitted infection (STI) testing by enabling users to collect samples at home and receive accurate, lab-validated results. Molecular Testing Labs is a US-based diagnostic company that provides at-home STI testing.

Regional Insights

North America was the largest region in the at-home sexually transmitted infection (STI) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the At-Home Sexually Transmitted Infection (STI) Testing Market?

The at-home sexually transmitted infection (STI) testing market consists of revenues earned by entities by providing services such as online consultation with healthcare professionals, digital result reporting and tracking, prescription and treatment guidance, and partner notification support. The market value includes the value of related goods sold by the service provider or included within the service offering. The at-home sexually transmitted infection (STI) testing market also includes sales of HIV self-test kits, chlamydia and gonorrhea dual test kits, syphilis rapid test kits, and HPV home screening kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What is the Market Assessment and Strategic Outlook for the At-Home Sexually Transmitted Infection (STI) Testing Industry?

The at-home sexually transmitted infection (sti) testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the at-home sexually transmitted infection (sti) testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the At-Home Sexually Transmitted Infection (STI) Testing Market Report 2026?

The at-home sexually transmitted infection (STI) testing market research report is one of a series of new reports from The Business Research Company that provides at-home sexually transmitted infection (STI) testing market statistics, including at-home sexually transmitted infection (STI) testing industry global market size, regional shares, competitors with a at-home sexually transmitted infection (STI) testing market share, detailed at-home sexually transmitted infection (STI) testing market segments, market trends and opportunities, and any further data you may need to thrive in the at-home sexually transmitted infection (STI) testing industry. This at-home sexually transmitted infection (STI) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.